ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Fabhalta 200 mg, Hartkapseln - 56
68603001 Novartis Pharma Schweiz AG
Fabhalta 200 mg, Hartkapseln29.08.2024
  29.08.2024
(L04AJ08) 
WHO-DDD28.08.2029
07.15.56
07.15. 
A  
Yes 
IPCI
24998.27Yes
    
10 %25956.05
  
7680686030015Synthetika
  
Composition
iptacopanum 200 mg ut iptacopani hydochloridum monohydricum, Kapselhülle: gelatina, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Iptacopanum200 mg
BAG: Active AgentDose
Iptacopanum200 mg
 
Inactive agents additional_information
(Flavum)  
(Nigrum)  
(Rubrum)  
Ammoniae Solutio Concentrata  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Pro Capsula  
Propylenglycol  
 
Source
Data was imported : 07.05.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home